Fluidnatek to Showcase at Medical Technology Germany its new LE-50 Gen2 Electrospinning System for Biomedical applications

Fluidnatek is pleased to announce its participation in Medical Technology Germany 2025. Visit us at stand 105 to discover the new LE-50 Gen2, our latest electrospinning and electrospraying platform for advanced R&D with nanofibers and nanoparticles, designed to accelerate innovation in the biomedical field.

The LE-50 Gen2 is a versatile benchtop system that combines needle-based and needleless technologies in a single unit. It supports dual-solution processing (hybrid structures made out of nanofibers of two different materials), independent high-voltage control, and automated scanning emitter motion for high homogeneity —ideal for developing multi-material scaffolds used in tissue engineering, wound healing, drug delivery, and medical device coatings.

Electrospinning technology enables the fabrication of nanofibre-based scaffolds that closely mimic the extracellular matrix, supporting cell growth and tissue regeneration. Also a great controlled release of active ingredients can be performed by the electrospun materials. With precise control and scalability, the LE-50 Gen2 is a powerful tool for advancing next-generation medical technologies.

Join us at stand 105 for live demonstrations and to discuss how Fluidnatek's solutions can support your biomedical applications.